Aceruloplasminemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 14: | Line 14: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
'''Aceruloplasminemia''' is an [[autosomal]] [[recessive]]<ref>{{cite journal |pmid=7708681 |year=1995 |month=March |author=Harris, Zl; Takahashi, Y; Miyajima, H; Serizawa, M; Macgillivray, Rt; Gitlin, Jd |title=Aceruloplasminemia: molecular characterization of this disorder of iron metabolism |volume=92 |issue=7 |pages=2539–43 |issn=0027-8424 |pmc=42253 |journal=Proceedings of the National Academy of Sciences of the United States of America |doi=10.1073/pnas.92.7.2539}}</ref> disorder of [[iron]] [[metabolism]] characterized by progressive [[neurodegeneration]] of the [[retina]] and [[basal ganglia]] and [[diabetes mellitus]]. | '''Aceruloplasminemia''' is an [[autosomal]] [[recessive]]<ref>{{cite journal |pmid=7708681 |year=1995 |month=March |author=Harris, Zl; Takahashi, Y; Miyajima, H; Serizawa, M; Macgillivray, Rt; Gitlin, Jd |title=Aceruloplasminemia: molecular characterization of this disorder of iron metabolism |volume=92 |issue=7 |pages=2539–43 |issn=0027-8424 |pmc=42253 |journal=Proceedings of the National Academy of Sciences of the United States of America |doi=10.1073/pnas.92.7.2539}}</ref> disorder of [[iron]] [[metabolism]] characterized by progressive [[neurodegeneration]] of the [[retina]] and [[basal ganglia]] and [[diabetes mellitus]]. | ||
| Line 30: | Line 30: | ||
{{Mineral metabolic pathology}} | {{Mineral metabolic pathology}} | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
Latest revision as of 19:45, 8 August 2012
| Aceruloplasminemia | |
| ICD-10 | E83.1 |
|---|---|
| ICD-9 | 275.0 |
| OMIM | 604290 |
| DiseasesDB | 30055 |
Overview
Aceruloplasminemia is an autosomal recessive[1] disorder of iron metabolism characterized by progressive neurodegeneration of the retina and basal ganglia and diabetes mellitus.
Iron accumulates in the pancreas, liver and brain. Accumulation in the eye may lead to retinal degeneration. The disease is caused by mutations in the ceruloplasmin gene.[2]
References
- ↑ Harris, Zl; Takahashi, Y; Miyajima, H; Serizawa, M; Macgillivray, Rt; Gitlin, Jd (1995). "Aceruloplasminemia: molecular characterization of this disorder of iron metabolism". Proceedings of the National Academy of Sciences of the United States of America. 92 (7): 2539–43. doi:10.1073/pnas.92.7.2539. ISSN 0027-8424. PMC 42253. PMID 7708681. Unknown parameter
|month=ignored (help) - ↑ Yoshida, K; Furihata, K; Takeda, S; Nakamura, A; Yamamoto, K; Morita, H; Hiyamuta, S; Ikeda, S; Shimizu, N; Yanagisawa, N (1995). "A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans". Nature genetics. 9 (3): 267–72. doi:10.1038/ng0395-267. PMID 7539672. Unknown parameter
|month=ignored (help)
See also
Template:Mineral metabolic pathology